Delay in diagnosis: Trauma- and coinfection-related cutaneous leishmaniasis because of Leishmania guyanensis infection

Journal of Cutaneous Pathology

Volumn 36, Issue 1, 2009, Pages 53-60

  Mulvaney, Patrick ^a   Aram, Gazelle ^a   Maggiore, Peter R ^b   Kutzner, Heinz ^c   Carlson, John Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b St Peter's Professional Building ^*  (United States)

^c Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; ITRACONAZOLE; METHAMPHETAMINE; MINOCYCLINE; PENTAVALENT ANTIMONY; PROTOZOAL DNA; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AGED; ARTICLE; BACTERIUM IDENTIFICATION; BRAZIL; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DNA EXTRACTION; ENDEMIC DISEASE; EXCISION; FOLLOW UP; FUNGUS IDENTIFICATION; GRANULOMATOUS INFLAMMATION; HEALING; HISTOCHEMISTRY; HUMAN; LEISHMANIA; LYMPH NODE BIOPSY; LYMPHANGIITIS; LYMPHANGITIS; LYMPHATIC SYSTEM DISEASE; MALE; MICROBIAL IDENTIFICATION; MIXED INFECTION; PAPULE; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; RECURRENT DISEASE; SCAR FORMATION; SENSITIVITY AND SPECIFICITY; SILVER STAINING; SKIN ABRASION; SKIN BIOPSY; SKIN INJURY; SKIN LEISHMANIASIS; SKIN ULCER; SPOROTHRIX; STAPHYLOCOCCUS LUGDUNENSIS; TISSUE CULTURE; TRAVEL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; ULCER; YEAST;

AGED; ANIMALS; ANTI-BACTERIAL AGENTS; BRAZIL; DNA, PROTOZOAN; ELBOW; HUMANS; LEISHMANIA GUYANENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; POLYMERASE CHAIN REACTION; SKIN; SPOROTHRIX; SPOROTRICHOSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 58149242732     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00925.x     Document Type: Article

References (61)

1. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004 27 : 305.
2. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003 49 : 50.
3. Wortmann GW, Aronson NE, Miller RS, Blazes D, Oster CN. Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 2000 31 : 199.
4. Rotureau B, Ravel C, Nacher M, et al. Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol 2006 44 : 468.
5. Kean BH. Cutaneous leishmaniasis on the Isthmus of Panama. Arch Derm Syph 1944 50 : 237.
6. Long PI. Cutaneous leishmaniasis treated with metronidazole. JAMA 1973 223 : 1378.
7. Walton BC, Valverde L. Evidence for trauma as a preciptating factor of American leishmaniasis after occult infection. In Proceedings of the Third International Congress of Parasitology, Munich, 1974. Vienna : Facta Publication, 1974 1571 [abstract F6(13)].
8. White SW, Hendricks LD. American cutaneous leishmaniasis. Int J Dermatol 1982 21 : 86.
9. Berger TG, Meltzer MS, Oster CN. Lymph node involvement in leishmaniasis. J Am Acad Dermatol 1985 12 : 993.
10. Walton BC. American cutaneous and mucocutaneous leishmaniasis. In Peters W, Killick-Kendrick R, eds. The leishmaniases in biology and medicine. Orlando : Academic Press, 1987 643.
11. Didona B, Gobello T, Vittucci V, Bergamo F, Cavalieri R. Leishmaniosi cutanea a noduli multpli disseminati. Chron Derm 1988 87 : 133.
12. Rab MA, Hassan M, Bux D, Mahmood MT, Evans DA. The isolation and cultivation of Leishmania infantum from apparently normal skin of visceral leishmaniasis patients in northern Pakistan. Trans R Soc Trop Med Hyg 1992 86 : 620.
13. McWhinney PH, Mir N, Love WC, Boyd JF. Cutaneous leishmaniasis presenting as a postoperative granuloma. J R Soc Med 1993 86 : 236.
14. Barrio J, Lecona M, Cosin J, Olalquiaga FJ, Hernanz JM, Soto J. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient. Br J Dermatol 1996 134 : 164.
15. Czechowicz RT, Millard TP, Smith HR, Ashton RE, Lucas SB, Hay RJ. Reactivation of cutaneous leishmaniasis after surgery. Br J Dermatol 1999 141 : 1113.
16. Marovich MA, Lira R, Shepard M, et al. Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment. Clin Infect Dis 2001 33 : 1076.
17. Ferreli C, Atzori L, Zucca M, Pistis P, Aste N. Leishmaniasis of the lip in a patient with Down's syndrome. J Eur Acad Dermatol Venereol 2004 18 : 599.
18. Wolf R, Lotti T, Ruocco V. Isomorphic versus isotopic response: data and hypotheses. J Eur Acad Dermatol Venereol 2003 17 : 123.
19. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999 341 : 1817.
20. Prats N, Ferrer L. A possible mechanism in the pathogenesis of cutaneous lesions in canine leishmaniasis. Vet Rec 1995 137 : 103.
21. Bertho AL, Santiago MA, Coutinho SG. An experimental model of the production of metastases in murine cutaneous leishmaniasis. J Parasitol 1994 80 : 93.
22. Travi BL, Osorio Y, Saravia NG. The inflammatory response promotes cutaneous metastasis in hamsters infected with Leishmania (Viannia) panamensis. J Parasitol 1996 82 : 454.
23. de Rossell RA, de Duran RJ, Rossell O, Rodriguez AM. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg 1992 86 : 251.
24. Oliveira-Neto MP, Mattos M, Souza CS, Fernandes O, Pirmez C. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 1998 37 : 846.
25. Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998 178 : 911.
26. Mirzabeigi M, Farooq U, Baraniak S, Dowdy L, Ciancio G, Vincek V. Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient. J Cutan Pathol 2006 33 : 701.
27. Tuon FF, Sabbaga Amato V, Floeter-Winter LM, et al. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int J Dermatol 2007 46 : 628.
28. Vardy DA, Cohen A, Kachko L, Zvulunov A, Frankenburg S. Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule. Br J Dermatol 1999 141 : 914.
29. Amato VS, Rabello A, Rotondo-Silva A, et al. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients. Acta Trop 2004 92 : 127.
30. Gillis D, Klaus S, Schnur LF, et al. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1995 14 : 247.
31. Guevara P, Ramirez JL, Rojas E, Scorza JV, Gonzalez N, Anez N. Leishmania braziliensis in blood 30 years after cure. Lancet 1993 341 : 1341.
32. Mary C, Faraut F, Drogoul MP, et al. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 2006 75 : 858.
33. Premoli-de-Percoco G, Gonzalez N, Anez N, Guevara P, Ramirez JL. PCR detection of specific Leishmania-DNA in patients with periodontal disease. Pathologica 2002 94 : 28.
34. Colebunders R, Depraetere K, Verstraeten T, et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999 41 : 847.
35. Bosch RJ, Rodrigo AB, Sanchez P, de Galvez MV, Herrera E. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol 2002 41 : 670.
36. Forsyth SF, Lawn SD, Miller RF, Fernando JJ, Lockwood DN, Vega-Lopez F. Multiple dermatofibroma-like lesions in a human immunodeficiency virus-positive patient coinfected with visceral leishmaniasis. Br J Dermatol 2003 148 : 185.
37. Elamin EM, Guerbouj S, Musa AM, et al. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Trans R Soc Trop Med Hyg 2005 99 : 803.
38. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997 276 : 75.
39. Ansari NA, Ramesh V, Salotra P. Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 2006 194 : 958.
40. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A 1993 90 : 3442.
41. Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993 118 : 883.
42. de Lima Barros MB, Schubach A, Francesconi-do-Valle AC, et al. Positive Montenegro skin test among patients with sporotrichosis in Rio De Janeiro. Acta Trop 2005 93 : 41.
43. Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis 2004 17 : 185.
44. Black CM, Bermudez LE, Young LS, Remington JS. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens. J Exp Med 1990 172 : 977.
45. Ismail A, Gadir AF, Theander TG, Kharazmi A, El Hassan AM. Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes. J Cutan Pathol 2006 33 : 778.
46. Chagnon A, Carli P, Paris JF, Cameli M, Carloz E. Carpian tunnel syndrome: a most unusual presentation of leishmaniasis. Eur J Med 1993 2 : 314.
47. Kirkpatrick CE, Nolan TJ, Farrell JP. Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology 1987 94 : 451.
48. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infect Immun 2002 70 : 2288.
49. Guarneri C, Guarneri F. Symmetrical cutaneous leishmaniasis. Acta Derm Venereol 2005 85 : 281.
50. Jafari AK, Akhyani M, Valikhani M, Ghodsi ZS, Barikbin B, Toosi S. Bilateral cutaneous leishmaniasis of upper eyelids: a case report. Dermatol Online J 2006 12 : 20.
51. de Castro EA, Soccol VT, Membrive N, Luz E. [Epidemiological and clinical study of 332 cases of cutaneous leishmaniasis in the north of Parana State from 1993 to 1998]. Rev Soc Bras Med Trop 2002 35 : 445.
52. Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol 2007 25 : 203.
53. Weedon D. Protozoal infections. In Weedon D, ed. Skin pathology. Edinburgh : Churchill Livingstone, 2002 719.
54. Chargui N, Bastien P, Kallel K, et al. Usefulness of PCR in the diagnosis of cutaneous leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg 2005 99 : 762.
55. Bensoussan E, Nasereddin A, Jonas F, Schnur LF, Jaffe CL. Comparison of PCR assays for diagnosis of cutaneous leishmaniasis. J Clin Microbiol 2006 44 : 1435.
56. Wortmann GW, Romero LI, Paz HM, et al. Real-time polymerase chain reaction diagnosis of leishmaniasis in Panama from both fresh and frozen tissue. Trans R Soc Trop Med Hyg 2004 98 : 148.
57. Ramirez JR, Agudelo S, Muskus C, et al. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol 2000 38 : 3768.
58. Lanus EC, Pinero JE, Gonzalez AC, Valladares B, de Grosso ML, Salomon OD. Detection of Leishmania braziliensis in human paraffin-embedded tissues from Tucuman, Argentina by polymerase chain reaction. Mem Inst Oswaldo Cruz 2005 100 : 187.
59. Arevalo J, Ramirez L, Adaui V, et al. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 2007 195 : 1846.
60. Romero GA, Vinitius De Farias Guerra M, Gomes Paes M, de Oliveira Macedo V. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin Infect Dis 2001 32 : 1304.
61. Haider S, Boutross-Tadross O, Radhi J, Momar N. Cutaneous ulcer in a man returning from Central America. CMAJ 2003 168 : 590.